Suchergebnisse - "Simonetta Viviani"

PubPharm (23)

1

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

in: HemaSphere | 2023

von Manuel Gotti | Roberta Sciarra | Alessandro Pulsoni | +38

2

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children

in: Human Vaccines & Immunotherapeutics | 2023

von Samba O. Sow | Milagritos D. Tapia | Fadima Cheick Haidara | +15

3

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials

in: HemaSphere | 2022

von Simonetta Viviani | Chiara Pavoni | Sally F. Barrington | +14

4

P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome

in: HemaSphere | 2022

von Theodoros P. Vassilakopoulos | Athanasios Liaskas | Giuliana Rizzuto | +26

5

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations

in: Communications Biology | 2022

von Claudia Maria Trombetta | Giulia Piccini | Giulio Pierleoni | +18

6

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers

in: HemaSphere | 2022

von Simonetta Viviani | Anna Vanazzi | Samuele Frassoni | +17

7

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination

in: Journal of Immunology Research | 2022

von Francesca Dapporto | Serena Marchi | Margherita Leonardi | +13

8

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac

in: Vaccines | 2022

von Simonetta Viviani

9

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

in: Vaccines | 2022

von Claudia Maria Trombetta | Otfried Kistner | Emanuele Montomoli | +2

10

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees

in: Human Vaccines & Immunotherapeutics | 2022

von Francesca Dapporto | Margherita Leonardi | Claudia Maria Trombetta | +18